Better late than sorry. If there's still value in the company and if a buyer steps up, that would be the spark needed. But Provenge is cheap to make and sell. There are other competing drugs nowadays
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.